NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.08 Cr |
Mar2023 | ₹-1.08 Cr |
Mar2022 | ₹-1.08 Cr |
Mar2021 | ₹-1.08 Cr |
Mar2020 | ₹-1.30 Cr |
How is Cash Flow from Financing Activities of NGL FINECHEM Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.08 Cr | Negative | |
Mar2023 | ₹-1.08 Cr | Negative | |
Mar2022 | ₹-1.08 Cr | Negative | |
Mar2021 | ₹-1.08 Cr | Negative | |
Mar2020 | ₹-1.30 Cr | - |
Compare Cash Flow from Financing Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹851.5 Cr | 8.1% | 32.6% | -45.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 8.1% |
32.6% |
-45.3% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses